Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran

被引:7
作者
Bordbar, Mohammadreza [1 ]
Haghpanah, Sezaneh [1 ]
Afrasiabi, Abdolreza [1 ]
Dehbozorgian, Javad [1 ]
Karimi, Mehran [1 ]
机构
[1] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
关键词
beta-thalassemia intermedia; beta-thalassemia major; Genotype; Lipid profiles; OXIDATIVE STRESS; HYPOCHOLESTEROLEMIA; CHILDREN;
D O I
10.1016/j.jacl.2011.12.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Beta-thalassemia is commonly associated with lipid abnormalities. The aim of this study was to search for links between these lipid alterations and different types of beta-thalassemia mutations. METHODS: The study, conducted from 2009 to 2010, included 100 patients with thalassemia major (TM) and 100 with thalassemia intermedia (TI). The control group was selected from 100 age- and sex-matched healthy individuals with normal hematologic indices. Serum lipid profiles, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG), were determined and their relationship with different covariates, including different beta-globin gene mutations, was analyzed. RESULTS: Patients with TI had significantly lower values for TC, LDL-C, HDL-C, and LDL-C/HDL-C ratio compared with TM patients and controls (P < .001). TG was greater in TM compared with TI patients (P = .001) and healthy individuals (P = .007). Hemoglobin was positively associated with TC (P < .001), LDL-C (P = .004), and HDL-C (P = .01) in TM patients. Splenectomy correlated with greater TC (P = .006) and LDL-C (P = .01) in TI patients, but only with greater LDL-C in TM patients (P = .02). The average amounts of TC and LDL-C were lower in persons with the beta(0)/beta(0) mutation compared with the beta(+)/beta(+) group. CONCLUSION: Lower amounts of TG, TC, LDL-C, and HDL-C were seen in TI patients compared with TM patients and healthy individuals. The severity of the genotype (ie, beta(0) type mutations compared with beta(+) type mutations) affected the degree of reduction in serum lipids. (C) 2012 National Lipid Association. All rights reserved.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 22 条
[1]   Thalassemia in Iran - Epidemiology, prevention, and management [J].
Abolghasemi, Hassan ;
Amid, Ali ;
Zeinali, Sirous ;
Radfar, Mohammad H. ;
Eshghi, Peyman ;
Rahiminejad, Mohammad S. ;
Ehsani, Mohammad A. ;
Najmabadi, Hossein ;
Akbari, Mohammad T. ;
Afrasiabi, Abdolreza ;
Akhavan-Niaki, Haleh ;
Hoofar, Hamid .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (04) :233-238
[2]  
Al-Quobaili FA, 2004, SAUDI MED J, V25, P871
[3]  
Atac Bulent, 2003, Heart Dis, V5, P65, DOI 10.1097/01.HDX.0000050420.79522.09
[4]   New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines [J].
Brewer, HB .
CLINICAL CARDIOLOGY, 2003, 26 (04) :19-24
[5]   Plasma lipid composition and LDL oxidation [J].
Brizzi, P ;
Tonolo, G ;
Carusillo, F ;
Malaguarnera, M ;
Maioli, M ;
Musumeci, S .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (01) :56-60
[6]   Distribution of serum lipids and lipoproteins in patients with beta thalassaemia major; an epidemiological study in young adults from Greece [J].
Christina Chrysohoou ;
Demosthenes B Panagiotakos ;
Christos Pitsavos ;
Konstantina Kosma ;
John Barbetseas ;
Markisia Karagiorga ;
Ioannis Ladis ;
Christodoulos Stefanadis .
Lipids in Health and Disease, 3 (1)
[7]   Amelioration of Oxidative Stress in Red Blood Cells from Patients with β-thalassemia Major and Intermedia and E-β-thalassemia Following Administration of a Fermented Papaya Preparation [J].
Fibach, Eitan ;
Tan, Ee-Shien ;
Jamuar, Saumya ;
Ng, Ivy ;
Amer, Johnny ;
Rachmilewitz, Eliezer A. .
PHYTOTHERAPY RESEARCH, 2010, 24 (09) :1334-1338
[8]   The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia [J].
Fibach, Eitan ;
Rachmilewitz, Eliezer A. .
COOLEY'S ANEMIA: NINTH SYMPOSIUM, 2010, 1202 :10-16
[9]   Protective effects of tea polyphenols against oxidative damage to red blood cells [J].
Grinberg, LN ;
Newmark, H ;
Kitrossky, N ;
Rahamim, E ;
Chevion, M ;
Rachmilewitz, EA .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (09) :973-978
[10]  
Haghpanah S, 2010, J RES MED SCI, V15, P150